GenomtecID Respiratory Panel 5-Plex (RP5-PLEX)
Respiratory Tract Infections (viral and bacterial)
ApprovedActive
Key Facts
Indication
Respiratory Tract Infections (viral and bacterial)
Phase
Approved
Status
Active
Company
About Genomtec
Genomtec is an emerging player in the point-of-care molecular diagnostics space, with a flagship CE-IVD marked product for respiratory infections. The company is actively pursuing growth through capital raises, M&A activities, and expansion into Asian markets, as indicated by recent news. Founded in 2022 and based in Wrocław, Poland, it has garnered significant recognition through various innovation awards and competitions, signaling strong technological promise.
View full company profile